- Report
- October 2024
- 186 Pages
Global
From €3247EUR$3,545USD£2,764GBP
€3607EUR$3,939USD£3,071GBP
- Report
- March 2025
- 144 Pages
Global
From €2747EUR$2,999USD£2,338GBP
- Report
- April 2025
- 307 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- April 2025
- 200 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- April 2025
- 200 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- December 2024
- 175 Pages
Global
From €4579EUR$5,000USD£3,899GBP
- Report
- March 2025
- 175 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- May 2024
- 130 Pages
United States
From €5449EUR$5,950USD£4,639GBP
- Report
- December 2023
- 80 Pages
United States
From €5449EUR$5,950USD£4,639GBP
- Report
- February 2024
- 119 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- May 2024
- 200 Pages
Global
From €3801EUR$4,150USD£3,236GBP
- Report
- March 2024
- 150 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- February 2024
- 185 Pages
North America
From €3160EUR$3,450USD£2,690GBP
- Report
- October 2023
- 146 Pages
Africa, Middle East
From €3160EUR$3,450USD£2,690GBP
- Report
- October 2023
- 145 Pages
From €3160EUR$3,450USD£2,690GBP
- Report
- July 2023
- 198 Pages
Europe
From €3160EUR$3,450USD£2,690GBP
- Report
- June 2023
- 184 Pages
Asia Pacific
From €3160EUR$3,450USD£2,690GBP
- Report
- March 2023
- 185 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- May 2022
- 180 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- February 2024
- 140 Pages
Global
From €4551EUR$4,969USD£3,874GBP

Fluorine-18 (F-18) is a radioactive isotope used in Nuclear Medicine and Radiopharmacy. It is produced in a cyclotron and is used in positron emission tomography (PET) imaging. F-18 is used to diagnose and monitor a variety of diseases, including cancer, heart disease, and neurological disorders. It is also used to measure the effectiveness of treatments. F-18 has a short half-life of 110 minutes, so it must be produced and used quickly.
F-18 is used in a variety of radiopharmaceuticals, including Fluorodeoxyglucose (FDG), which is used to detect cancer. Other radiopharmaceuticals include Sodium Fluoride (NaF), which is used to detect bone metastases, and Fluoromisonidazole (FMISO), which is used to detect hypoxia.
The F-18 market is highly competitive, with many companies offering radiopharmaceuticals and PET imaging services. Some of the major players in the market include GE Healthcare, Siemens Healthineers, Mallinckrodt Pharmaceuticals, and Jubilant DraxImage. Show Less Read more